GEN-1 Added to Chemo Improves Removal of Ovarian Tumors, Early Data Show
News
The immunotherapy candidate GEN-1 has shown encouraging results in patients newly diagnosed with advanced ovarian cancer, according to initial results of the OVATION 2 study. Adding GEN-1 to neoadjuvant chemotherapy ... Read more